Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: a factorial dose-escalation study

Randomized controlled trial in 16 healthy participants showing bidirectional metabolic interactions between DMT and harmine via transmucosal delivery. Dose-dependent subjective effects lasting 4-5 hours with favorable safety characteristics for therapeutic development.